New DNA “shredder” technique goes beyond CRISPR’s scissors

CRISPR Tool borrowed from bacteria successfully seeks out, cuts and destroys long stretches of human cells’ DNA, opening doors to new uses in research and treatment

Author | Kara Gavin

In the last six years, a tool called CRISPR-Cas9 has transformed genetic research, allowing scientists to snip and edit DNA strands at precise locations like a pair of tiny scissors.

But sometimes, it takes more than scissors to do the job.

Now, a collaborative international team has unveiled a new CRISPR-based tool that acts more like a shredder, able to wipe out long stretches of DNA in human cells with programmable targeting.

Writing in Molecular Cell, they describe how they succeeded in getting a different kind of CRISPR-Cas system called Type I CRISPR-Cas3 to work as long-range DNA editing tool in human cells for the first time.

The resulting tool provides a way to target and delete much longer expanses of DNA than current Cas9 tools can. That power could be put to work in genetic research to understand the underpinnings of disease -- and potentially in treatment for diseases tied to long stretches of DNA.  

Yan Zhang, Ph.D., the University of Michigan scientist who led the research, explains that the new tool harnesses a different type of CRISPR system than the Cas9-containing ones widely used . Both are borrowed from bacteria, where they normally function to find and weed out invading DNA.

A representation of how the new technique is made possible in human cells (top box) and how it acts on DNA to create long-range deletions starting at a precise point.

A different type of CRISPR

The new tool uses a Type I CRISPR, which is much more common in bacteria than the Type II variety that includes Cas9. Type I CRISPR has never been used in any eukaryotic cells, and employs a riboprotein complex known as Cascade for seeking its target and an enzyme called Cas3 for shredding DNA.

The challenging protein optimization and purification side of the work was done in the laboratory of Cornell University professor Ailong Ke, Ph.D., a co-corresponding author of the paper. Cornell graduate student Adam Dolan and U-M senior research specialist Zhonggang Hou, Ph.D. are the paper’s first authors.

The research involved a long shot by Zhang, who has studied bacterial CRISPR-Cas9 and developed tools for editing genetic material in human cells, and Ke, who has studied Type I CRISPR using structural and biochemical approaches.

They set out to try to deliver the bacterial CRISPR components as proteins into both human embryonic stem cells and another type of cell called HAP1. With one CRISPR guide, the team succeeded in deleting portions of targeted DNA ranging from a few hundred base pairs to 100 kilobases.

A motorized shredder

Zhang calls the Cascade-Cas3 system a “DNA shredder with a motor” because it can move along a DNA genome for a certain distance, breaking up the genetic material as it goes.

“Cas9 is a molecular scissor that goes where you want it and snips once,” says Zhang, an assistant professor of biological chemistry at the U-M Medical School. “But Cas3 goes where you want it, travels along the chromosome, and makes a spectrum of deletions tens of kilobases long. This could make it a powerful screening tool to determine what large areas of DNA are most important for a particular disease.”

This could be especially useful when scientists are studying the “non-coding” long stretches of DNA that don’t contain the code for a particular protein; the “shredder” technique could allow them to demolish a sequence of long stretches and see what happens.

In addition, the ability of Cas3 to travel on the chromosome over a long distance can’t be done with any current Cas9 technique. So a “nuclease dead” version of Cas3 that can travel along DNA but lacks the shredder function might provide a powerful delivery platform for long-range epigenome engineering.

Scientific challenges

Part of the research effort involved figuring out how to get the human stem cells to reveal if any DNA had been deleted, since most of the stem cell “reporter” lines developed for research involving CRISPR-Cas9 are not sensitive enough if the shredding activity is low. Sara Howden, Ph.D. of the University of Melbourne, Australia, worked on building a sensitive, dual-reporter cell line.

Another challenge for the team was to figure out what the shredder had shredded after the deed was done, using next-generation DNA sequencing and going beyond existing methods to look at the small edits that Cas9 produces.

Hou developed a transposase-based profiling method, and Peter Freddolino, Ph.D., an assistant professor of biological chemistry and computational medicine and bioinformatics at U-M, built custom informatics pipelines to analyze the deep sequencing results.

Ke also notes in the paper that because the guide RNA sequence needed to tell the “shredder” where to go is longer than the sequences used in CRISPR-Cas9 systems, and also because target searching and degradation are two well-separated steps, the new method is potentially better controlled. It may be less likely to make mistaken cuts where they’re not wanted.

This new tool and its derivatives could be useful for therapeutic purposes, Zhang speculates, though such use is years in the future.

Some CRISPR-Cas9-based therapeutic uses have been reported – including a controversial editing out of a receptor gene that enables HIV to enter cells in the embryos of two babies reportedly born in China. But worries about CRISPR-Cas9 making unintended edits in normal areas of human patients’ DNA have also surfaced. Further work will be needed to see if the “shredder” approach avoids this issue.

U-M and Cornell have filed for a joint patent on this new tool. The research was funded by the National Institutes of Health (GM128637, GM118174, GM102543 and GM117268) and by Zhang’s funding from the Medical School’s Biological Sciences Scholars Program.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Featured News & Stories family of four sitting on couch in living room looking at an ipad laughing
Health Lab
Grandparents help grandkids in many ways – but the reverse may be true too
A poll shows the many ways (childcare, nutrition, major expenses) that grandparents help their grandchildren, but also suggests a link to older adults’ sense of isolation and their mental health.
Minding Memory with a microphone and a shadow of a microphone on a blue background
Minding Memory
Can a personalized music intervention reduce behavioral disturbances in dementia?
While memory loss is generally thought of as the hallmark of dementia, behavioral and psychological symptoms of dementia like agitation, aggression, anxiety, and hallucinations are nearly universal, affecting almost all patients with advanced dementia. These behavioral disturbances are often the trigger for nursing home placement, and they can be highly distressing for both patients and their care partners. In today’s episode, Matt and Lauren speak with Dr. Ellen McCreedy, a researcher from the Brown School of Public Health who has conducted a study of personalized music intervention called Music & Memory for people living with dementia in nursing homes. Dr. McCreedy is a gerontologist and health services researcher who focuses on evaluation of non-pharmacologic interventions for managing behavioral disturbances of people living with dementia.
cell formation in grey and then two circles highlighed blue and one red
Health Lab
The solution to death from a fentanyl overdose could lie in its chemical structure
University of Michigan researchers may have found that the solution to prevent people from dying from a fentanyl overdose may be found within fentanyl's own chemistry.
man recovering on left in hospital gown in hospital room and on right with friends taking selfie in michigan gear
Health Lab
Michigan fan saved after wife recognizes stroke at football game
After a man suffered a stroke at a University of Michigan football game, his wife’s recognition of his symptoms helped him receive lifesaving treatment and make a full recovery.
Desmond Howard visits a patient at Mott. He is smiling and wearing a U-M alumni t-shirt and jeans. The patient is lying on a hospital bed and is covered with a white blanket.
Philanthropy News
“The Game” Could Pay Off Big for Little Victors: Join the Competition and Make a Difference
Join C.S. Mott Children's Hospital and Game Gives Back to turn the Michigan-Ohio State rivalry into crucial support for pediatric care and research.
close up of orange and purple squiggle-looking cells merging and a little green in the middle
Health Lab
Researchers find metabolic mechanism that blocks immune response, immunotherapy in cancer
New research has discovered why some cancers don’t respond to immunotherapy treatment: A metabolite transporter within the tumor microenvironment blocks a key type of tumor cell death integral to immune response.